This site is intended for healthcare professionals
News

Lilly begins a phase III clinical trial with baricitinib for hospitalized COVID-19 patients.

Read time: 1 mins
Last updated:16th Jun 2020
Published:16th Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com